FNBT
BHC icon

FineMark National Bank & Trust’s Bausch Health BHC Stock Holding History

FineMark National Bank & Trust’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24
Closed -$3K – 1300
2015
Q4 		$3K Buy
24
+15
+167% +$1.69K ﹤0.01% 1097
2015
Q3 		$2K Sell
9
-157
-95% -$36.6K ﹤0.01% 1225
2015
Q2 		$37K Sell
166
-258
-61% -$57.2K ﹤0.01% 731
2015
Q1 		$84K Buy
424
+68
+19% +$12.1K 0.01% 530
2014
Q4 		$51K Sell
356
-34
-9% -$4.57K 0.01% 659
2014
Q3 		$51K Buy
390
+36
+10% +$4.29K 0.01% 623
2014
Q2 		$45K Buy
354
+3
+0.9% +$383 0.01% 658
2014
Q1 		$46K Buy
351
+57
+19% +$7.79K 0.01% 632
2013
Q4 		$35K Sell
294
-2
-0.7% -$219 0.01% 672
2013
Q3 		$31K Hold
296
– – 0.01% 673
2013
Q2 		$25K Buy
+296
New +$23.3K 0.01% 722

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

FineMark National Bank & Trust's BHC Position: Q1 2016 in Review

FineMark National Bank & Trust sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 24 shares — an estimated $3K sold.

FineMark National Bank & Trust first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $84K in Q1 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • FineMark National Bank & Trust reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • FineMark National Bank & Trust sold 24 Bausch Health shares in Q1 2016, an estimated $3K.
  • FineMark National Bank & Trust first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
  • FineMark National Bank & Trust's Bausch Health position peaked at $84K in Q1 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on FineMark National Bank & Trust's 13F filing for Q1 2016, filed 10 May 2016.